- Home
- SUZ vs PEN Comparison
SUZ vs PEN Comparison
Compare SUZ & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUZ
- PEN
- Stock Information
- Founded
- SUZ 1924
- PEN 2004
- Country
- SUZ Brazil
- PEN United States
- Employees
- SUZ N/A
- PEN N/A
- Industry
- SUZ Paper
- PEN Medical/Dental Instruments
- Sector
- SUZ Basic Materials
- PEN Health Care
- Exchange
- SUZ Nasdaq
- PEN Nasdaq
- Market Cap
- SUZ 12.1B
- PEN 10.6B
- IPO Year
- SUZ N/A
- PEN 2015
- Fundamental
- Price
- SUZ $9.73
- PEN $272.95
- Analyst Decision
- SUZ
- PEN Strong Buy
- Analyst Count
- SUZ 0
- PEN 16
- Target Price
- SUZ N/A
- PEN $300.47
- AVG Volume (30 Days)
- SUZ 1.5M
- PEN 418.9K
- Earning Date
- SUZ 10-23-2025
- PEN 10-29-2025
- Dividend Yield
- SUZ 2.72%
- PEN N/A
- EPS Growth
- SUZ 3585.36
- PEN 916.05
- EPS
- SUZ 1.16
- PEN 3.74
- Revenue
- SUZ $9,414,799,585.00
- PEN $1,280,152,000.00
- Revenue This Year
- SUZ $9.16
- PEN $15.52
- Revenue Next Year
- SUZ $17.10
- PEN $14.20
- P/E Ratio
- SUZ $8.31
- PEN $72.93
- Revenue Growth
- SUZ 27.38
- PEN 12.92
- 52 Week Low
- SUZ $8.41
- PEN $184.80
- 52 Week High
- SUZ $10.98
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- SUZ 52.44
- PEN 70.17
- Support Level
- SUZ $9.65
- PEN $261.99
- Resistance Level
- SUZ $9.87
- PEN $268.81
- Average True Range (ATR)
- SUZ 0.14
- PEN 7.46
- MACD
- SUZ -0.02
- PEN 2.29
- Stochastic Oscillator
- SUZ 36.12
- PEN 98.59
About SUZ Suzano S.A.
Suzano SA produces and sells pulp and a variety of paper products. The company organizes itself into two segments based on product type: Pulp and Paper. The Pulp segment generates the majority of revenue. The firm's product portfolio includes printing and writing paper, paperboard, diapers, and sanitary napkins. The company owns forest land and plants in Brazil, where it harvests timber and turns the timber into pulp and paper in its plants.
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.